| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |